Skip to content

Assessment of orally administered Pistacia atlantica gum medicine in the treatment of gastrointestinal disease

Formulation of Pistacia atlantica gum soft gelatin capsule and its clinical efficacy assessment in the eradication of Helicobacter Pylori

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130313012810N4
Enrollment
100
Registered
2021-05-11
Start date
2021-04-21
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Peptic ulcer. Condition 2: Peptic ulcer. Peptic ulcer, site unspecified Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation

Interventions

Intervention 1: Intervention group: receiving standard treatment of 3 different drugs: Amoxicillin 500 mg (2 times daily), Clarithromycin 500 mg (twice daily), omeprazole 20 mg (twice daily) plus a ca

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Urease positive peptic ulcer suffering patients

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Known cases of gastric ulcer and malignant duodenal ulcer Patients taking nonsteroidal anti-inflammatory drugs (NSAIDs), blood thinners, or antibiotics 4 weeks before the urease breath test Patients who received a combination of bismuth 2 weeks before the urea test Patients receiving proton pump inhibitors or any antacids 3 days before the urease breath test

Design outcomes

Primary

MeasureTime frame
Percentage of patients converting urease test positive to negative. Timepoint: 14 days after starting to use Pistacia atlantica gum soft gelatin capsule. Method of measurement: Measurement of CO2 in exhalation by carbon analyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Hamishehkar

Tabriz University of Medical Sciences

hamishehkar.hamed@gmail.com+98 41 3336 3311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026